Clinical Trial Details
— Status: Enrolling by invitation
Administrative data
NCT number |
NCT06300047 |
Other study ID # |
REB23-0679 |
Secondary ID |
|
Status |
Enrolling by invitation |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
June 1, 2024 |
Est. completion date |
December 31, 2028 |
Study information
Verified date |
October 2023 |
Source |
University of Calgary |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
The goal of this interventional study is to assess the effects and evaluate the
implementation of a pediatric to adult care transition intervention in youth with T1D on
clinical, patient-reported, and implementation outcomes, including an economic analysis.
The 3 main aims are:
1. To assess the effects of our transition intervention on clinical and patient-reported
outcomes.
2. To implement the transition intervention and evaluate the implementation outcomes.
3. To evaluate the economic impacts of the transition intervention. Participants will have
access to a transition coordinator before, during, and after their planned transition
from pediatric to adult care as standard of care.
Researchers will compare a pre-intervention cohort to evaluate the impact of the transition
coordinator intervention.
Description:
Both usual care and intervention groups will receive routine diabetes care as per Canadian
national guidelines. Usual care (routine care) includes regular appointments with their
pediatric diabetes care team (i.e., pediatric endocrinologist, diabetes nurse or dietician)
and post-transfer with their adult diabetes team (i.e., physician and as needed visits with a
diabetes educator and/or a dietician). The transition process usually starts at age 14 with
discussions during clinic with youth and families around increased autonomy, self-care,
organization of adult healthcare services and specific transition topics such as driving,
drugs, alcohol, relationships, finances and living away from home.
The usual care group is defined as the group who receives usual care and serves as the
control group. This group is defined prior to the implementation of the intervention. We
include a two month wash out period between our two groups to avoid care providers 'holding
on' to patients they feel may benefit from the intervention.
The intervention group (in addition to usual care) is provided additional support by way of a
non-medical transition coordinator during the transition and transfer from pediatric to adult
diabetes care. The non-medical transition coordinator encourages problem solving,
self-management skills, and supports navigating the 'adult world'. In the year prior to
transfer, the transition coordinator will meet each participant in person or virtually once
during their routine pediatric diabetes appointment to explain their role prior to transfer.
The transition coordinator role includes the following tasks: (1) use of text messaging,
email, or phone communication (as per participant's preference) to maintain contact with the
participant every 2 months for 12 months past the transfer date; (2) use of text messaging,
email, or telephone as needed when participants reach out to them to answer any questions
whereby the transition coordinator would provide direction; (3) assisting participants with
finding family physicians (if needed); (4) assisting with completion of financial assistance,
disability, insurance forms; (4) addressing any stated psychosocial needs by relaying
information on community supports for participants and families; and, (5) maintaining a
private Facebook® page and a transition website in which participants were encouraged to use.
Website contents include information on transition, adult diabetes care (i.e., location,
contact numbers, what to expect in adult care), diabetes resources as well as mental health
resources. The website will be updated to have information relevant to each implementation
site. We may add other types of social media to share information about transition (i.e.,
TikTok, Instagram), and this will be considered during our pre-implementation phase. The
transition coordinator will not provide any medical advice or counselling.